Boston Scientific Settles With Ex-Partner
23rd Sep 2005, 05:36 GMT
Boston Scientific has agreed to pay $750 mln to its former partner in a settlement that ends a bitter contract dispute over the sale of heart stents.
Latest news from Angiography/ Cardiac Cath News from StratCenter.com:
- Thinking Systems Releases Enhanced PET-CT Functions for Its ThinkingPACS
- Tallahassee Memorial Hospital at the Forefront in Treatment of Heart Attack Patients
- Preliminary Long-Term Clinical Data Show Promising Results for the CYPHER Sirolimus-eluting Coronary Stent in Patients With Multi-Vessel Disease